Literature DB >> 8213120

Revision of the PCA unicompartmental knee. 52 arthrosis knees followed for 2-5 years.

A Harilainen1, J Sandelin, P Ylinen, V Vahvanen.   

Abstract

We evaluated 52 unicompartmental PCA arthroplasties for primary (46) or secondary (6) arthrosis after 3 (2-5) years. Cementless fixation was used in 35 femoral and in 28 tibial components. There were indications for revision in 11 cases. Conversion to a total knee had been performed in 4 cases, and 1 tibial as well as 1 femoral component had been exchanged, mainly because of polyethylene wear with increasing deformity. 2 femoral components were loose and 1 had fractured.

Entities:  

Mesh:

Year:  1993        PMID: 8213120     DOI: 10.3109/17453679308993659

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  4 in total

1.  High rate of implant loosening for uncemented resurfacing-type medial unicompartmental knee arthroplasty.

Authors:  Danilo Bruni; Stefano Zaffagnini; Francesco Iacono; Laura Bragonzoni; Mirco Lo Presti; Maria Pia Neri; Giulio Maria Marcheggiani Muccioli; Marco Nitri; Giovanni Raspugli; Maurilio Marcacci
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-11-22       Impact factor: 4.342

Review 2.  Cementless fixation in medial unicompartmental knee arthroplasty: a systematic review.

Authors:  S Campi; H G Pandit; C A F Dodd; D W Murray
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-07-19       Impact factor: 4.342

3.  Lateral unicompartmental knee replacement: a systematic review of reasons for failure.

Authors:  Lukas Ernstbrunner; Mohamed A Imam; Octavian Andronic; Tabea Perz; Karl Wieser; Sandro F Fucentese
Journal:  Int Orthop       Date:  2017-10-13       Impact factor: 3.075

4.  Comparison of the 10-year outcomes of cemented and cementless unicompartmental knee replacements: data from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man.

Authors:  Hasan R Mohammad; Gulraj S Matharu; Andrew Judge; David W Murray
Journal:  Acta Orthop       Date:  2019-10-22       Impact factor: 3.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.